ACRS
Aclaris Therapeutics, Inc. · Healthcare
Chief Scientific Officer Joseph Monahan sold $386K of Aclaris Therapeutics, Inc.
Sold$385,639
$12.51Price
30,837Shares
−17%Stake
What ACRS did after the filing
- The stock from Fri, Mar 3 close, $12.78
- −25.1%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 17 close.
Traded Thu, Mar 2. Filed Fri, Mar 3, 3:12 PM ET, during the session. Returns use the Mar 3 close and the Apr 17 close. Not investment advice.